ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,628Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 807

$524K Total Retail Price of All Prescriptions

Rank: 99 out of 807

519 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 10,768 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 841 774 1 1
LISINOPRIL 570 550 2 2
FUROSEMIDE 511 496 3 6
OMEPRAZOLE 482 464 4 4
METOPROLOL TARTRATE 465 431 5 8
WARFARIN SODIUM 445 442 6 10
CITALOPRAM HBR 351 338 7 17
AMLODIPINE BESYLATE 328 301 8 5
HYDROCHLOROTHIAZIDE 257 251 9 9
LEVOTHYROXINE SODIUM 254 243 10 3
METFORMIN HCL 241 238 11 12
ATENOLOL 226 225 12 7
POTASSIUM CHLORIDE 223 202 13 18
LOSARTAN POTASSIUM 197 196 14 14
GABAPENTIN 166 108 15 16
PRAVASTATIN SODIUM 165 153 16 21
ALLOPURINOL 145 140 17 26
ISOSORBIDE MONONITRATE ER 142 142 18 36
ATORVASTATIN CALCIUM 137 135 19 11
TAMSULOSIN HCL 126 97 20 27
NAMENDA 119 105 21 54
TERAZOSIN HCL 113 112 22 78
MIRTAZAPINE 111 93 23 38
METOPROLOL SUCCINATE 108 100 24 13
JANUVIA 103 99 25 79
CLOPIDOGREL 101 100 26 47
LIDODERM 100 97 27 96
ALENDRONATE SODIUM 98 77 28 20
SERTRALINE HCL 88 84 29 22
RANITIDINE HCL 88 83 29 34
FLUTICASONE PROPIONATE 84 81 31 30
TRAZODONE HCL 83 42 32 25
ZOLPIDEM TARTRATE 82 79 33 23
TRAMADOL HCL 78 72 34 19
HYDROCODONE-ACETAMINOPHEN 78 68 S3 34 15
DOXAZOSIN MESYLATE 77 77 36 70
DONEPEZIL HCL 74 74 37 31
METFORMIN HCL ER 72 65 38 61
TRIAMCINOLONE ACETONIDE 72 67 38 98
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 64 40 28
PLAVIX 65 62 41 60
PRAMIPEXOLE DIHYDROCHLORIDE 64 62 42 121
PREDNISONE 64 61 42 24
CYMBALTA 62 48 44 73
PROAIR HFA 61 52 45 43
GLIMEPIRIDE 60 60 46 51
CRESTOR 56 54 47 32
CARVEDILOL 53 53 48 35
PANTOPRAZOLE SODIUM 52 52 49 44
SYNTHROID 52 52 49 127
SPIRIVA 51 51 51 50
FENOFIBRATE 51 50 51 69
LOVASTATIN 50 50 53 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.